Skip to main
  1. Stocks
  2. Encompass Health
  3. Forecast
EHC

Encompass Health (EHC) Stock Forecast & Price Target

Encompass Health (EHC) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Encompass Health is positioned to compound growth through an under-supplied inpatient rehabilitation network, with 3Q26 revenue of $1.61B and adjusted EBITDA of $346.6M beating expectations while margins expanded to 21.5%. Its outlook is supported by strong volume trends, higher-acuity mix gains in neuro, stroke, brain injury and major trauma, and meaningful VA demand, which helped lift FY26 guidance to $6.45B-$6.50B of revenue and $1.395B-$1.415B of adjusted EBITDA. The company also has a disciplined growth engine with 145-190 bed additions in 2026, net leverage of 1.8x, and robust free cash flow that supports further investment, buybacks, and dividend growth.

Bears say

Encompass Health is exposed to persistent margin pressure because staffing costs and turnover remain elevated while reimbursement generally lags, leaving profitability vulnerable even as patient volume has recently recovered. Its outlook is further weakened by regulatory and payer risks, since CMS has generally issued more onerous reimbursement and regulatory provisions and could reduce IRF rates while Medicare Advantage plans may pressure admissions. The company also faces execution risk from de novo facilities and bed additions that may ramp slower than expected, plus a tight labor market for therapists, nurses, and other professionals with wage inflation outpacing price growth.

Encompass Health (EHC) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.

Encompass Health (EHC) Analyst Forecast & Price Prediction

Get the latest Encompass Health (EHC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Encompass Health (EHC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Encompass Health (EHC) Forecast

Analysts have given Encompass Health (EHC) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Encompass Health (EHC) has a Strong Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $154.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $154.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Encompass Health (EHC)


Encompass Health (EHC) Analyst Forecast & Price Prediction

Get the latest Encompass Health (EHC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Encompass Health (EHC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover EHC stock data and trends